PMID- 32581828 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200928 IS - 1664-042X (Print) IS - 1664-042X (Electronic) IS - 1664-042X (Linking) VI - 11 DP - 2020 TI - MiR-181d-5p Targets KLF6 to Improve Ischemia/Reperfusion-Induced AKI Through Effects on Renal Function, Apoptosis, and Inflammation. PG - 510 LID - 10.3389/fphys.2020.00510 [doi] LID - 510 AB - Renal tubular epithelial cell (RTEC) death and renal interstitial inflammation are the most crucial pathophysiological changes in acute kidney ischemia/reperfusion injury (IRI). The microRNA (miR)-181d family plays diverse roles in cell proliferation, apoptosis and inflammation, but its renal target and potential role in IRI are unknown. Here, we showed that the expression of miR-181d-5p decreased and Krueppel-like factor 6 (KLF6) increased in a renal cell (HK-2) model of hypoxia/reoxygenation (H/R) injury and a mouse model of renal IRI. They were mainly distributed in the renal tubules. After renal IRI, miR-181d-5p overexpression significantly inhibited inflammatory mediators, reduced apoptosis and further improved renal function. KLF6 exacerbated RTEC damage and acted as a NF-kappaB co-activator to aggravate the renal IRI inflammatory response. Mechanistically, KLF6 was predicted as a new potential target gene of miR-181d-5p through bioinformatic analysis and luciferase reporter assay verification. After overexpressing miR-181d-5p and inhibiting KLF6, the role of miR-181d-5p was weakened on the renal damage improvement. In conclusion, miR-181d-5p upregulation produced protective antiapoptotic and anti-inflammatory effects against IRI in kidneys in vivo and H/R injury in HK-2 cells in vitro, and these effects were achieved by targeted inhibition of KLF6. Thus, our results provide novel insights into the molecular mechanisms associated with IRI and a potential novel therapeutic target. CI - Copyright (c) 2020 Zhang, Li, Guan, Zhou, Wang, Yang, Zhen, Dai, Zhao, Jiang and Xu. FAU - Zhang, Yue AU - Zhang Y AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Li, Chenyu AU - Li C AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. AD - Nephrologisches Zentrum, Ludwig Maximilian University of Munich, Munich, Germany. FAU - Guan, Chen AU - Guan C AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Zhou, Bin AU - Zhou B AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Wang, Lin AU - Wang L AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Yang, Chengyu AU - Yang C AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Zhen, Li AU - Zhen L AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Dai, Jie AU - Dai J AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Zhao, Long AU - Zhao L AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Jiang, Wei AU - Jiang W AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Xu, Yan AU - Xu Y AD - Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China. LA - eng PT - Journal Article DEP - 20200527 PL - Switzerland TA - Front Physiol JT - Frontiers in physiology JID - 101549006 PMC - PMC7295155 OTO - NOTNLM OT - IRI OT - KLF6 OT - MiR-181d-5p OT - apoptosis OT - inflammation OT - renal function EDAT- 2020/06/26 06:00 MHDA- 2020/06/26 06:01 PMCR- 2020/05/27 CRDT- 2020/06/26 06:00 PHST- 2020/02/27 00:00 [received] PHST- 2020/04/27 00:00 [accepted] PHST- 2020/06/26 06:00 [entrez] PHST- 2020/06/26 06:00 [pubmed] PHST- 2020/06/26 06:01 [medline] PHST- 2020/05/27 00:00 [pmc-release] AID - 10.3389/fphys.2020.00510 [doi] PST - epublish SO - Front Physiol. 2020 May 27;11:510. doi: 10.3389/fphys.2020.00510. eCollection 2020.